Form 8-K - Current report:
SEC Accession No. 0000950170-24-092432
Filing Date
2024-08-07
Accepted
2024-08-07 12:07:11
Documents
11
Period of Report
2024-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20240801.htm   iXBRL 8-K 38309
  Complete submission text file 0000950170-24-092432.txt   176714

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20240801.xsd EX-101.SCH 42846
13 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20240801_htm.xml XML 5351
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 241182468
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)